• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Legal roundup: St. Jude wins; Covidien, Masimo settle; Novartis sues

Legal roundup: St. Jude wins; Covidien, Masimo settle; Novartis sues

January 31, 2011 By MassDevice staff

Legal roundup

St. Jude Medical Inc. (NYSE:STJ) declared victory in the latest round of litigation between its subsidiary, LightLab Imaging Inc., and Volcano Corp. (NSDQ:VOLC) subsidiary Axsun Technologies Inc.

The Mass. Superior Court found that San Diego, Calif.-based Volcano and Billerica, Mass.-based Axsun violated state law “through a pattern of inappropriate conduct directed at key technology used in the company’s Optical Coherence Tomography product platform,” St. Jude said in prepared remarks.

The statutory violations arose in connection with Volcano’s acquisition of Axsun Technologies, a LightLab supplier, in 2008. The court also found that these violations were knowing and willful and entitle LightLab to recover attorneys’ fees. In its decision, the court found that Volcano viewed the Axsun acquisition as a means of “impeding the growth of a major competitor,” that there was a “scheme orchestrated by Volcano and implemented with Axsun’s assistance” to seek to supply LightLab with a less effective laser, and that this would “adversely affect the marketability” of LightLab’s imaging system, according to St. Jude.

Before its acquisition by St. Jude, Westford, Mass.-based LightLab launched a suit against Axsun accusing it of violating a contract the companies signed prior to Axsun’s 2008 acquisition by Volcano.

The latest decision adopts Feb. 2010 findings from a Mass. Superior Court jury that Axsun violated the contract with LightLab, which covers its agreement to supply tunable lasers to LightLab until 2016. The jury also found that Volcano interfered with LightLab’s business relationship with Axsun.

Last October, Volcano was able to declare a victory in the ongoing legal battle when Mass. Superior Court rejected LightLab’s claims for protection of five alleged trade secrets relating to laser technologies and denied all of the coronary imaging firm’s requests for permanent injunctions.

There was news on two other legal fronts as well, between Covidien plc (NYSE:COV)and Masimo Corp. (NSDQ:MASI) and between Novartis AG (NYSE:NVS) and a trio of biopharm companies:

  • Covidien and Masimo extend royalty agreement
    Covidien plc and Masimo Corp. said they amended a settlement agreement initially reached in January 2006. Under the terms of the amendment, Danvers, Mass.-based Covidien will pay Masimo a royalty of 7.75 percent for pulse oximetry products sold in the U.S. for three years, beginning March 15.

    Masimo is assessing the full financial impact of the amendment on its 2011 financial outlook ahead of releasing its 2010 results Feb. 15, the company said. As part of that assessment, the Irvine, Calif.-based firm is considering the possibility of re-investing up to 50 percent of the royalty revenue this year.
    Read more

  • Novartis launches legal attack on three biopharm firms over genetic diagnostics IP
    Novartis AG (NYSE:NVS)’s Novartis Vaccines and Diagnostics Inc. division accused AstraZeneca plc (NYSE:AZN) subsidiary MedImmune LLC, Biogen Idec Inc. (NSDQ:BIIB) and Alexion Pharmaceuticals Inc. (NSDQ:ALXN) of manufacturing treatments that copy its diagnostic gene sequencing technology. The suit, filed Jan. 26 in the U.S. District Court for Delaware, claims that AstraZeneca’s Synagis respiratory treatment, Biogen’s Tysabri treatment for multiple sclerosis and Alexion’s Soliris treatment for a type of anemia all infringe a patent MedImmune acquired in 1997.

Filed Under: Business/Financial News, Legal News, News Well, Patent Infringement Tagged With: Covidien, LightLab Imaging, Masimo, Novartis, stjudemedical, Volcano Corp.

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy